期刊
BIOCHEMISTRY
卷 45, 期 5, 页码 1511-1517出版社
AMER CHEMICAL SOC
DOI: 10.1021/bi0520129
关键词
-
资金
- NIGMS NIH HHS [GM48677] Funding Source: Medline
- NIMH NIH HHS [MH53631, R01 MH053631, R01 MH053631-11S1, R01 MH053631-11] Funding Source: Medline
The alpha 9 and alpha 10 nicotinic acetylcholine receptor (nAChR) subunits assemble to form the alpha 9 alpha 10 nAChR subtype. This receptor is believed to mediate cholinergic synaptic transmission between efferent olivocochlear fibers and the hair cells of the cochlea. In addition alpha 9 and/or alpha 10 expression has been described in dorsal root ganglion neurons, lymphocytes, skin keratinocytes, and the pars tuberalis of the pituitary. Specific antagonists that selectively block the alpha 9 alpha 10 channel could be valuable tools for elucidating its role in these diverse tissues. This study describes a novel alpha-conotoxin from the Western Atlantic species Conus regius, alpha-conotoxin RgIA (alpha-RgIA), that is a subtype specific blocker of the alpha 9 alpha 10 nAChR. alpha-RgIA belongs to the alpha 4/3 subfamily of the alpha-conotoxin family; sequence and subtype specificity comparisons between alpha-RgIA and previously characterized alpha 4/3 toxins indicate that the amino acids in the C-terminal half of alpha-RgIA are responsible for its preferential inhibition of the alpha 9 alpha 10 nAChR subtype.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据